Prader-Willi syndrome groups call attention to possible safety risks with Vykat XR

A joint statement issued by three organizations warned healthcare professionals about potential safety risks for patients receiving a newly approved therapy to treat Prader-Willi syndrome. Prader-Willi Syndrome Association USA, the Foundation for Prader-Willi Research and the International Prader-Willi Syndrome Organization released a statement to raise awareness about reports of serious adverse